Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

CEP63 Inhibitors

CEP63 inhibitors constitute a specialized category of chemical compounds that have garnered attention in the field of molecular biology and cellular centrosome regulation research. CEP63, or Centrosomal Protein 63, is a protein localized at the centrosome, a critical cellular organelle responsible for microtubule organization, cell division, and cell polarity. CEP63 inhibitors is a group of molecules meticulously designed to selectively target and modulate the activity of CEP63. These inhibitors serve as invaluable tools in laboratory investigations, enabling researchers to explore the intricate molecular functions and cellular processes associated with CEP63. CEP63 inhibitors typically function by interfering with the interactions or functions of CEP63 within the centrosome, potentially disrupting centrosomal architecture, microtubule organization, and cellular processes reliant on proper centrosome function. This interference can lead to alterations in cell division, cellular polarity, and microtubule dynamics, impacting various aspects of cellular behavior and function. Researchers employ CEP63 inhibitors to gain insights into the physiological roles and molecular interactions of CEP63 within cells, aiming to advance our understanding of the fundamental mechanisms involved in centrosome regulation, cell division, and cellular organization. Through the study of CEP63 inhibitors, scientists seek to unravel the complexities of centrosome biology, mitotic processes, and the broader field of cell biology, contributing to our knowledge of how cells orchestrate their structural and organizational dynamics.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Sirolimus is known to inhibit mTOR, which could lead to reduced protein synthesis, potentially affecting CEP63 expression levels.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Mitomycin C crosslinks DNA, which could inhibit DNA replication and transcription, potentially resulting in decreased CEP63 expression.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$84.00
$306.00
$1104.00
30
(3)

Aphidicolin selectively inhibits DNA polymerase, which may result in reduced DNA replication and potentially lower CEP63 levels.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin inhibits DNA topoisomerase I, which could lead to reduced DNA transcription and potentially decreased CEP63 expression.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide inhibits DNA topoisomerase II, potentially reducing transcription and thereby affecting CEP63 expression levels.

Acrylamide Solution, 40%

79-06-1sc-3721
1 L
$100.00
(1)

Acrylamide can form adducts with DNA and proteins, which may disrupt various cellular processes, possibly affecting CEP63 expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib inhibits proteasome activity, which could lead to altered regulatory pathways and potentially reduced CEP63 expression.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Flavopiridol inhibits cyclin-dependent kinases, which may result in cell cycle arrest and potentially lower CEP63 levels.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine can affect DNA and RNA synthesis by intercalating into nucleic acids, which may reduce CEP63 expression.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 selectively inhibits MEK1/2, which could lead to downstream effects on cell cycle regulation and potentially affect CEP63 expression.